217 related articles for article (PubMed ID: 33670012)
1. BAF57/SMARCE1 Interacting with Splicing Factor SRSF1 Regulates Mechanical Stress-Induced Alternative Splicing of Cyclin D1.
Feng J; Xu X; Fan X; Yi Q; Tang L
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33670012
[No Abstract] [Full Text] [Related]
2. N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons.
Kazantseva A; Sepp M; Kazantseva J; Sadam H; Pruunsild P; Timmusk T; Neuman T; Palm K
J Neurochem; 2009 May; 109(3):807-18. PubMed ID: 19245665
[TBL] [Abstract][Full Text] [Related]
3. A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex.
Hah N; Kolkman A; Ruhl DD; Pijnappel WW; Heck AJ; Timmers HT; Kraus WL
Cancer Res; 2010 Jun; 70(11):4402-11. PubMed ID: 20460533
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
[TBL] [Abstract][Full Text] [Related]
5. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
Link KA; Balasubramaniam S; Sharma A; Comstock CE; Godoy-Tundidor S; Powers N; Cao KH; Haelens A; Claessens F; Revelo MP; Knudsen KE
Cancer Res; 2008 Jun; 68(12):4551-8. PubMed ID: 18559499
[TBL] [Abstract][Full Text] [Related]
6. Expression of BAF57 in ovarian cancer cells and drug sensitivity.
Yamaguchi T; Kurita T; Nishio K; Tsukada J; Hachisuga T; Morimoto Y; Iwai Y; Izumi H
Cancer Sci; 2015 Apr; 106(4):359-66. PubMed ID: 25611552
[TBL] [Abstract][Full Text] [Related]
7. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
[TBL] [Abstract][Full Text] [Related]
8. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
[TBL] [Abstract][Full Text] [Related]
9. Cellular senescence regulated by SWI/SNF complex subunits through p53/p21 and p16/pRB pathway.
He L; Chen Y; Feng J; Sun W; Li S; Ou M; Tang L
Int J Biochem Cell Biol; 2017 Sep; 90():29-37. PubMed ID: 28716547
[TBL] [Abstract][Full Text] [Related]
10. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.
Moulton VR; Gillooly AR; Perl MA; Markopoulou A; Tsokos GC
PLoS One; 2015; 10(7):e0131073. PubMed ID: 26134847
[TBL] [Abstract][Full Text] [Related]
11. Assembly and interaction of core subunits of BAF complexes and crystal study of the SMARCC1/SMARCE1 binary complex.
Dong C; Zhang R; Xu L; Liu B; Chu X
Biochem Biophys Res Commun; 2022 Apr; 599():9-16. PubMed ID: 35158202
[TBL] [Abstract][Full Text] [Related]
12. SRSF1-3, a splicing and somatic hypermutation regulator, controls transcription of IgV genes via chromatin regulators SATB2, UBN1 and histone variant H3.3.
Singh AK; Tamrakar A; Jaiswal A; Kanayama N; Kodgire P
Mol Immunol; 2020 Mar; 119():69-82. PubMed ID: 31986311
[TBL] [Abstract][Full Text] [Related]
13. Splicing factor-modulated generation of mechano growth factor regulates physiological processes in osteoblasts under mechanical stimuli.
Yi Q; Liu H; Feng J; Wu Y; Sun W; Ou M; Tang L
Cell Adh Migr; 2019 Dec; 13(1):322-331. PubMed ID: 31680616
[TBL] [Abstract][Full Text] [Related]
14. RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1.
Lee M; Dworkin AM; Gildea D; Trivedi NS; ; Moorhead GB; Crawford NP
Oncogene; 2014 Apr; 33(14):1818-27. PubMed ID: 23604122
[TBL] [Abstract][Full Text] [Related]
15. Cyclic stretch induces VEGFA alternative splicing via Serine/Arginine-Rich Splicing Factor 1.
Xie ZW; Chen YX; Long CF; Qi YX; Yao QP
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):43-50. PubMed ID: 29974845
[TBL] [Abstract][Full Text] [Related]
16. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
Wahid M; Pratoomthai B; Egbuniwe IU; Evans HR; Babaei-Jadidi R; Amartey JO; Erdelyi V; Yacqub-Usman K; Jackson AM; Morris JC; Patel PM; Bates DO
Cancer Immunol Immunother; 2023 Dec; 72(12):4001-4014. PubMed ID: 37973660
[TBL] [Abstract][Full Text] [Related]
17. Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology.
Gonçalves V; Jordan P
Biomed Res Int; 2015; 2015():287048. PubMed ID: 26273603
[TBL] [Abstract][Full Text] [Related]
18. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF.
Link KA; Burd CJ; Williams E; Marshall T; Rosson G; Henry E; Weissman B; Knudsen KE
Mol Cell Biol; 2005 Mar; 25(6):2200-15. PubMed ID: 15743818
[TBL] [Abstract][Full Text] [Related]
19. Aberrant BAF57 signaling facilitates prometastatic phenotypes.
Balasubramaniam S; Comstock CE; Ertel A; Jeong KW; Stallcup MR; Addya S; McCue PA; Ostrander WF; Augello MA; Knudsen KE
Clin Cancer Res; 2013 May; 19(10):2657-67. PubMed ID: 23493350
[TBL] [Abstract][Full Text] [Related]
20. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
